IL1B and chronic kidney disease: In CKD patients, curcuminoid’s effects are poorly investigated; however, it has been found that in mononuclear cells isolated from CKD patients, 1–3 mM of curcumin decreases the secretion of Il-6 and IL-1ß and its procoagulant activity [152] (Table 2).